# Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)

> **NCT02854631** · PHASE2 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 104 (actual)

## Conditions studied

- Alcoholic Hepatitis (AH)

## Interventions

- **DRUG:** Selonsertib
- **DRUG:** Prednisolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02854631
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-01
- **Primary completion:** 2018-02-16
- **Final completion:** 2018-05-31
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2019-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02854631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02854631, "Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02854631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*